V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009756 | 220021350 | 1.91 | null | Palliative (P) | 2014-02-23 | 2014-03-10 | Methotrexate Intrathecal (any age) | N | N | 220033463 | PACLITAXEL |
| 220009757 | 220003995 | null | 72.55 | null | null | 2018-03-30 | Methotrexate Intrathecal (any age) | null | null | 220033581 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 220009758 | 220003995 | 1.49 | 65.8 | Curative (C) | 2015-03-20 | 2015-04-01 | Melphalan IV High dose | 2 | null | 220033581 | BOSUTINIB |
| 220009759 | 220016564 | null | null | Palliative (P) | 2016-10-30 | 2017-01-29 | Ipilimumab | N | N | 220033707 | ECF |
| 220009760 | 220003996 | 1.86 | 84.9 | Curative (C) | 2014-06-14 | 2014-06-15 | Doxorubin 50mg/m2 | 02 | N | 220033732 | UKALL2014 |
| 220009761 | 220003996 | 1.68 | 60.7 | Curative (C) | 2013-07-02 | 2013-07-07 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | N | 220033732 | CISPLATIN |
| 220009763 | 220003998 | 1.72 | 73.6 | Curative (C) | 2015-11-24 | 2015-12-05 | Carboplatin + Pemetrexed | N | N | 220033820 | METHOTREXATE INTRATHECAL |
| 220009764 | 220003998 | 1.68 | 53.7 | Palliative (P) | 2017-12-29 | 2017-12-29 | CHOP R - 21 days | 02 | N | 220033820 | ECARBOX |
| 220009765 | 220003999 | 1.76 | 73.6 | Curative (C) | 2017-01-14 | 2017-01-19 | IDARUBICIN | N | N | 220033943 | MITOXANTRONE |
| 220009766 | 220012129 | null | 86.2 | Curative (C) | 2018-03-21 | 2018-03-21 | Cisplatin + Vinorelbine (PO) | N | null | 220034024 | ARSENIC TRIOXIDE + TRETINOIN |
| 220009767 | 220012129 | null | null | null | 2016-05-30 | 2016-06-02 | Fludarabine + Melphalan RIC Allo | Y | N | 220034024 | MITOXANTRONE |
| 220009768 | 220012129 | 1.92 | 65.2 | Curative (C) | 2013-10-15 | 2013-10-17 | Arsenic trioxide + Tretinoin | null | null | 220034024 | PENTOSTATIN |
| 220009769 | 220012129 | 1.95 | 52.85 | Curative (C) | 2014-03-23 | 2014-03-23 | MITOXANTRONE + TRETINOIN | 02 | Y | 220034024 | CYTARABINE IT + METHOTREXATE |
| 220009770 | 220021351 | 1.75 | 74.2 | Curative (C) | 2015-10-03 | 2015-10-03 | IVAC | 02 | N | 220034122 | ALEMTUZUMAB |
| 220009771 | 220004000 | 1.65 | 90 | Curative (C) | 2018-04-21 | 2018-04-22 | BOSUTINIB | 2 | N | 220034158 | RUXOLITINIB |
| 220009772 | 220004001 | 1.62 | 65 | Curative (C) | 2019-01-13 | 2019-01-15 | LENALIDOMIDE | 02 | N | 220034188 | CYCLOPHOSPHAMIDE |
| 220009773 | 220012130 | 1.73 | 64.9 | Disease modification (D) | 2017-06-16 | 2017-06-16 | Triple / Double Intrathecal Therapy | N | N | 220034233 | IBRUTINIB |
| 220009774 | 220004002 | 0 | 55.6 | Disease modification (D) | 2017-09-12 | 2017-09-14 | ALL UKALL60+ TRIAL | 02 | N | 220034278 | LANREOTIDE |
| 220009775 | 220004002 | null | 44.8 | Curative (C) | 2018-07-20 | 2018-11-15 | Fludarabine + Melphalan RIC Allo | 2 | Y | 220034278 | CISPLATIN + FLUOROURACIL + RT |
| 220009776 | 220004002 | 1.85 | 135.3 | Palliative (P) | null | 2018-02-10 | Mitoxantrone | N | N | 220034278 | CARBOPLATIN + PEMETREXED |
| 220009777 | 220004003 | 1.66 | null | Curative (C) | 2014-08-11 | 2014-08-11 | Mitoxantrone | N | N | 220034508 | ARSENIC TRIOXIDE + ATRA |
| 220009778 | 220004004 | 1.78 | 96 | Disease modification (D) | 2017-03-15 | 2017-03-16 | CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA | 02 | N | 220034546 | IDARUBICIN |
| 220009779 | 220004005 | 1.67 | 72 | null | null | 2018-07-03 | Fludarabine + Melphalan RIC Allo | null | null | 220034547 | CVD |
| 220009780 | 220004006 | null | null | null | 2017-07-20 | 2017-07-20 | Capecitabine (21days) + Carboplatin | 99 | null | 220034552 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 220009781 | 220012132 | 1.58 | 97.2 | Curative (C) | 2017-04-02 | 2017-04-10 | Vemurafenib | 02 | N | 220034708 | CISPLATIN |
| 220009782 | 220004007 | 1.55 | null | Adjuvant (A) | 2015-04-04 | 2015-05-04 | IMATINIB + HYDROXYCARBAMIDE | N | N | 220034753 | RUXOLITINIB |
| 220009783 | 220004008 | null | 88.6 | Curative (C) | 2017-09-27 | 2017-10-03 | IPILIMUMAB + NIVOLUMAB | 02 | N | 220034781 | FIGARO TRIAL |
| 220009784 | 220004009 | 0 | 0 | Curative (C) | 2018-05-31 | 2018-06-19 | BOSUTINIB | N | N | 220034831 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220009785 | 220004010 | null | 44.3 | Curative (C) | 2018-04-01 | 2018-04-01 | UKALL14- Ph 1 Induction | 2 | N | 220034859 | UKALL2014 |
| 220009786 | 220004011 | null | 86 | Disease modification (D) | 2018-10-19 | 2018-10-20 | Vemurafenib | N | N | 220035112 | CYTARABINE INTRATHECAL |
| 220009787 | 220004012 | 1.89 | 0 | null | 2017-09-30 | 2017-09-30 | FCiSt | N | N | 220035162 | DOCETAXEL |
| 220009788 | 220004013 | null | 57 | Curative (C) | 2016-01-15 | 2016-01-15 | Cisplatin + Fluorouracil + RT 5day | 1 | null | 220035180 | ARSENIC TRIOXIDE |
| 220009789 | 220004014 | 0 | 92.8 | Curative (C) | 2017-02-19 | 2017-03-01 | DHAP | N | N | 220035216 | CYTARABINE + MITOXANTRONE |
| 220009790 | 220004015 | 1.64 | 0 | Disease modification (D) | 2018-02-28 | 2018-03-07 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220035239 | PANITUMUMAB |
| 220009791 | 220004015 | 1.72 | 77.4 | Curative (C) | 2015-04-21 | 2015-04-22 | Triple Intrathecal | 02 | null | 220035239 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220009792 | 220016567 | 1.59 | 121 | Palliative (P) | 2014-04-28 | 2014-04-28 | Cyclophosphamide High Dose | N | N | 220035346 | PACLITAXEL |
| 220009793 | 220016567 | 1.52 | 61 | Curative (C) | 2015-10-20 | 2015-11-11 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220035346 | CYTARABINE + MITOXANTRONE |
| 220009794 | 220004016 | 1.55 | 0 | Curative (C) | 2018-06-19 | 2018-07-08 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 220035438 | ATG + BUSULFAN + FLUDARABINE |
| 220009795 | 220004017 | null | 46.7 | null | 2014-11-08 | 2014-11-11 | Ipilimumab | 02 | N | 220035466 | ROMAZA TRIAL |
| 220009796 | 220004018 | null | null | Curative (C) | null | 2013-08-08 | OCTREOTIDE | N | N | 220035503 | VENETOCLAX |
| 220009797 | 220004018 | 1.69 | 67.6 | null | 2013-07-07 | 2013-08-23 | Carbo F | 2 | null | 220035503 | MELPHALAN |
| 220009798 | 220004018 | null | null | Palliative (P) | 2014-11-22 | 2014-11-22 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 220035503 | RUXOLITINIB |
| 220009799 | 220004019 | null | null | Curative (C) | null | 2018-07-24 | TOPARP TRIAL | N | N | 220035835 | CISPLATIN |
| 220009800 | 220004020 | 1.71 | 79.9 | Curative (C) | 2019-06-14 | 2019-06-22 | UKALL14- Maintenance | 02 | N | 220036148 | CYTARABINE + FLUDARABINE + IDARUBICIN |
| 220009801 | 220004021 | 1.69 | 47.05 | Palliative (P) | 2013-02-23 | 2013-02-24 | FCR Oral - Cycle 1 | null | N | 220036187 | PACLITAXEL |
| 220009802 | 220004022 | null | 72.85 | Curative (C) | 2019-03-22 | 2019-03-30 | CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA | N | N | 220036329 | MITOXANTRONE |
| 220009803 | 220004023 | 1.62 | 4 | Palliative (P) | null | 2019-04-28 | FEC + DOCETAXEL | N | N | 220036339 | IPILIMUMAB |
| 220009804 | 220004023 | 1.8 | null | Disease modification (D) | 2016-07-09 | 2016-08-01 | ECF | N | N | 220036339 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220009805 | 220004024 | 1.56 | 77 | Curative (C) | 2014-10-09 | 2014-10-16 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 220036512 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009806 | 220004024 | null | null | null | 2017-04-17 | 2017-04-17 | CAPECITABINE + RT | N | null | 220036512 | FLUDARABINE + MELPHALAN |